Literature DB >> 24272318

Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders.

Shigeto Nagao1, Osamu Yokota, Chikako Ikeda, Naoya Takeda, Hideki Ishizu, Shigetoshi Kuroda, Koichiro Sudo, Seishi Terada, Shigeo Murayama, Yosuke Uchitomi.   

Abstract

To study the relationship between neurodegenerative diseases including argyrophilic grain disease (AGD) and late-onset schizophrenia and delusional disorders (LOSD; onset ≥40 years of age), we pathologically examined 23 patients with LOSD, 71 age-matched normal controls, and 22 psychiatric disease controls (11 depression, six personality disorder, two bipolar disorders, and three neurotic disorders cases). In all LOSD cases (compared to age-matched normal controls), the frequencies of Lewy body disease (LBD), AGD, and corticobasal degeneration (CBD) were 26.1 % (11.3 %), 21.7 % (8.5 %), and 4.3 % (0.0 %), respectively. There was no case of pure Alzheimer's disease (AD). The total frequency of LBD, AGD, and CBD was significantly higher in LOSD cases than in normal controls. Argyrophilic grains were significantly more severe in LOSD than in controls, but were almost completely restricted to the limbic system and adjacent temporal cortex. In LOSD patients whose onset occurred at ≥65 years of age (versus age-matched normal controls), the frequencies of LBD and AGD were 36.4 % (19.4 %) and 36.4 % (8.3 %), respectively, and AGD was significantly more frequent in LOSD patients than in normal controls. In LOSD patients whose onset occurred at <65 years of age, the frequencies of LBD, AGD, and CBD were 16.7, 8.3, and 8.3 %, comparable to those of age-matched normal controls (10.2, 5.1, and 0.0 %). In all psychiatric cases, delusion was significantly more frequent in AGD cases than in cases bearing minimal AD pathology alone. Given these findings, LOSD patients may have heterogeneous pathological backgrounds, and AGD may be associated with the occurrence of LOSD especially after 65 years of age.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24272318     DOI: 10.1007/s00406-013-0472-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  64 in total

1.  A neuropathological study of vascular factors in late-life depression.

Authors:  A J Thomas; I N Ferrier; R N Kalaria; R H Perry; A Brown; J T O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

2.  Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria.

Authors:  H Braak; E Braak
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

3.  Can schizophrenia begin after age 44?

Authors:  P Rabins; S Pauker; J Thomas
Journal:  Compr Psychiatry       Date:  1984 May-Jun       Impact factor: 3.735

Review 4.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

5.  Incidence of silent cerebral infarction in patients with major depression.

Authors:  T Fujikawa; S Yamawaki; Y Touhouda
Journal:  Stroke       Date:  1993-11       Impact factor: 7.914

6.  Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations.

Authors:  Robert Perneczky; Alexander Drzezga; Henning Boecker; Hans Förstl; Alexander Kurz; Peter Häussermann
Journal:  Dement Geriatr Cogn Disord       Date:  2008-05-14       Impact factor: 2.959

7.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

8.  No increased incidence of Alzheimer's disease in elderly schizophrenics.

Authors:  K A Jellinger; E Gabriel
Journal:  Acta Neuropathol       Date:  1999-02       Impact factor: 17.088

9.  White matter tauopathy with globular glial inclusions: a distinct sporadic frontotemporal lobar degeneration.

Authors:  Gabor G Kovacs; Katalin Majtenyi; Salvatore Spina; Jill R Murrell; Ellen Gelpi; Romana Hoftberger; Graham Fraser; R Anthony Crowther; Michel Goedert; Herbert Budka; Bernardino Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  7 in total

1.  The neuropathology of schizophrenia: new insights from postmortem studies.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06       Impact factor: 5.270

Review 2.  Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.

Authors:  Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2022-01-04       Impact factor: 44.711

Review 3.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02

4.  Argyrophilic Grain Disease: Demographics, Clinical, and Neuropathological Features From a Large Autopsy Study.

Authors:  Roberta Diehl Rodriguez; Claudia Kimie Suemoto; Mariana Molina; Camila Fernandes Nascimento; Renata Elaine Paraizo Leite; Renata Eloah de Lucena Ferretti-Rebustini; José Marcelo Farfel; Helmut Heinsen; Ricardo Nitrini; Kenji Ueda; Carlos Augusto Pasqualucci; Wilson Jacob-Filho; Kristine Yaffe; Lea Tenenholz Grinberg
Journal:  J Neuropathol Exp Neurol       Date:  2016-06-09       Impact factor: 3.685

5.  Excess tau PET ligand retention in elderly patients with major depressive disorder.

Authors:  Sho Moriguchi; Keisuke Takahata; Hitoshi Shimada; Manabu Kubota; Soichiro Kitamura; Yasuyuki Kimura; Kenji Tagai; Ryosuke Tarumi; Hajime Tabuchi; Jeffrey H Meyer; Masaru Mimura; Kazunori Kawamura; Ming-Rong Zhang; Shigeo Murayama; Tetsuya Suhara; Makoto Higuchi
Journal:  Mol Psychiatry       Date:  2020-07-01       Impact factor: 15.992

Review 6.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

7.  Characteristics of very late-onset schizophrenia-like psychosis as prodromal dementia with Lewy bodies: a cross-sectional study.

Authors:  Hideki Kanemoto; Yuto Satake; Takashi Suehiro; Daiki Taomoto; Fuyuki Koizumi; Shunsuke Sato; Tamiki Wada; Keiko Matsunaga; Eku Shimosegawa; Mamoru Hashimoto; Kenji Yoshiyama; Manabu Ikeda
Journal:  Alzheimers Res Ther       Date:  2022-09-22       Impact factor: 8.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.